Reversal of the immunosuppressive tumor microenvironment via platinum-based neoadjuvant chemotherapy in cervical cancer

Background: Immunotherapy favors patients with tumors; however, only 3–26.3% of patients with cervical cancer benefit from single-agent immune checkpoint inhibitors. Combined immunotherapy and chemotherapy has been explored against tumor; however, the combination remains controversial. This study ai...

Full description

Bibliographic Details

Published in:	Cancer Pathogenesis and Therapy
Main Authors:	Xue Feng, Xiaolin Meng, Dihong Tang, Shuaiqingying Guo, Qiuyue Liao, Jing Chen, Qin Xie, Fengyuan Liu, Yong Fang, Chaoyang Sun, Yingyan Han, Jihui Ai, Kezhen Li
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Subjects:	Neoadjuvant chemotherapy Cervical cancer Tumor immune microenvironment Spatial architecture CD8 Regulatory T cells
Online Access:	http://www.sciencedirect.com/science/article/pii/S2949713223000460